- Home
- LSBK vs CBUS Comparison
LSBK vs CBUS Comparison
Compare LSBK & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBK
- CBUS
- Stock Information
- Founded
- LSBK 1891
- CBUS 2010
- Country
- LSBK United States
- CBUS United States
- Employees
- LSBK N/A
- CBUS N/A
- Industry
- LSBK Savings Institutions
- CBUS Agricultural Chemicals
- Sector
- LSBK Finance
- CBUS Industrials
- Exchange
- LSBK Nasdaq
- CBUS Nasdaq
- Market Cap
- LSBK 90.0M
- CBUS 75.5M
- IPO Year
- LSBK 2006
- CBUS 2017
- Fundamental
- Price
- LSBK $12.66
- CBUS $1.41
- Analyst Decision
- LSBK
- CBUS Strong Buy
- Analyst Count
- LSBK 0
- CBUS 3
- Target Price
- LSBK N/A
- CBUS $22.00
- AVG Volume (30 Days)
- LSBK 115.7K
- CBUS 190.8K
- Earning Date
- LSBK 07-23-2025
- CBUS 08-14-2025
- Dividend Yield
- LSBK 2.84%
- CBUS N/A
- EPS Growth
- LSBK 40.80
- CBUS N/A
- EPS
- LSBK 1.05
- CBUS N/A
- Revenue
- LSBK $26,488,000.00
- CBUS $4,846,000.00
- Revenue This Year
- LSBK N/A
- CBUS $31.23
- Revenue Next Year
- LSBK N/A
- CBUS $70.93
- P/E Ratio
- LSBK $12.09
- CBUS N/A
- Revenue Growth
- LSBK 1.75
- CBUS 63.66
- 52 Week Low
- LSBK $11.50
- CBUS $1.35
- 52 Week High
- LSBK $12.92
- CBUS $8.65
- Technical
- Relative Strength Index (RSI)
- LSBK 65.45
- CBUS 40.44
- Support Level
- LSBK $12.64
- CBUS $1.46
- Resistance Level
- LSBK $12.92
- CBUS $1.58
- Average True Range (ATR)
- LSBK 0.16
- CBUS 0.10
- MACD
- LSBK 0.03
- CBUS -0.00
- Stochastic Oscillator
- LSBK 71.74
- CBUS 20.69
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.